Waystar To Acquire Iodine Software in $1.25 Billion Deal

October 1, 2025

Waystar, a healthcare payments software provider, announced a definitive agreement to acquire Iodine Software for an enterprise value of $1.25 billion. The deal is designed to extend Waystar’s AI platform into clinical intelligence, combining Iodine’s clinical AI data assets with Waystar’s healthcare payments network.

Buyers
Waystar, Advent International
Targets
Iodine Software
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.